^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    EasyM™ assay

    Company:
    Rapid Novor
    Type:
    Laboratory Developed Test
    Details
    Evidence

    News

    1m
    Rapid Novor Announces Completion of Patient Enrollment in Princess Margaret Cancer Centre Study Evaluating EasyM® in Multiple Myeloma (PRWeb)
    "Rapid Novor Inc...has completed enrollment of 70 patients in a Canadian prospective study assessing the test’s clinical utility in newly diagnosed multiple myeloma (NDMM). Conducted in collaboration with Princess Margaret Cancer Centre (PMCC) and funded by a leading pharmaceutical partner, this study represents the first prospective Canadian study evaluating EasyM® for non-invasive MRD monitoring."
    Clinical
    |
    EasyM™ assay